Your browser doesn't support javascript.
loading
Wolfram syndrome 1 in the Italian population: genotype-phenotype correlations.
Rigoli, Luciana; Aloi, Concetta; Salina, Alessandro; Di Bella, Chiara; Salzano, Giuseppina; Caruso, Rosario; Mazzon, Emanuela; Maghnie, Mohamad; Patti, Giuseppa; D'Annunzio, Giuseppe; Lombardo, Fortunato.
Afiliación
  • Rigoli L; Department of Human Pathology, University of Messina, Messina, Italy.
  • Aloi C; LABSIEM (Laboratory for the Study of Inborn Errors of Metabolism), Istituto Giannina Gaslini, Genoa, Italy.
  • Salina A; LABSIEM (Laboratory for the Study of Inborn Errors of Metabolism), Istituto Giannina Gaslini, Genoa, Italy.
  • Di Bella C; Department of Human Pathology, University of Messina, Messina, Italy.
  • Salzano G; Department of Human Pathology, University of Messina, Messina, Italy.
  • Caruso R; Department of Human Pathology, University of Messina, Messina, Italy.
  • Mazzon E; IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy.
  • Maghnie M; Department of Pediatrics, University of Genoa, Istituto Giannina Gaslini, Genova, Italy.
  • Patti G; Department of Pediatrics, University of Genoa, Istituto Giannina Gaslini, Genova, Italy.
  • D'Annunzio G; Department of Pediatrics, Istituto Giannina Gaslini, Genova, Italy. GiuseppeDAnnunzio@gaslini.org.
  • Lombardo F; Department of Human Pathology, University of Messina, Messina, Italy.
Pediatr Res ; 87(3): 456-462, 2020 02.
Article en En | MEDLINE | ID: mdl-31266054
OBJECTIVES: We studied 45 patients with Wolfram syndrome 1 (WS1) to describe their clinical history and to search for possible genotype-phenotype correlations. METHODS: Clinical criteria contributing to WS1 diagnosis were analyzed. The patients were classified into three genotypic classes according to type of detected mutations. RESULTS: WS1 prevalence in Italy is 0.74/1,000,000. All four manifestations of DIDMOAD were found in 46.7% of patients. Differently combined WS1 clinical features were detected in 53.3% of patients. We found 35 WFS1 different mutations and a novel missense mutation, c.1523A>G. WS1 patients were homozygotes or compound heterozygotes for WFS1 mutations except for 2 heterozygote patients (4.5%). Each genotypic group exhibited a different age onset of DM, D, and DI but not of OA. Genotypic Group 2 patients manifested a lower number of clinical manifestations compared to Groups 1 and 3. Moreover, genotypic Group 1 patients tended to have a shorter survival time than the other groups. No differences were found regarding type of clinical pictures. CONCLUSIONS: Our study suggested that molecular WFS1 typing is a useful tool for early assessment of clinical history, follow-up, and prognosis of WS1.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Wolfram / Mutación Missense / Proteínas de la Membrana Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Pediatr Res Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Wolfram / Mutación Missense / Proteínas de la Membrana Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Pediatr Res Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos